During the past decade, Encore Medical Research of Boynton Beach conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Encore Medical Research of Boynton Beach" are "Arthritis" (1 trials), "Atopic Dermatitis" (1 trials), "Autoimmune Diseases" (1 trials), "Connective Tissue Diseases" (1 trials) and "Immune System Diseases" (1 trials). Many other conditions were trialed in "Encore Medical Research of Boynton Beach" in a lesser frequency.

Most popular intervention types in "Encore Medical Research of Boynton Beach" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ASLAN004" (1 trials), "Peresolimab" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Encore Medical Research of Boynton Beach" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Encore Medical Research of Boynton Beach". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Encore Medical Research of Boynton Beach, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Encore Medical Research of Boynton Beach, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".